IAPP and Alzheimer disease: Type 2 diabetes (T2D) has been identified as a risk factor for AD18, and both diseases are pathologically characterized by the presence of misfolded protein aggregates, which result in the formation of Aβ deposits in AD and amylin deposits in T2D19.